At a glance


45 mins


Seen in 1-6 months




From Affordable Price


Some discomfort, initial swelling and discomfort can be treated with ice and over-the-counter painkillers.


Brief Details About Belkyra

What is Belkyra?

Belkyra (also known as Kybella) is a prescription medication used to reduce the appearance of moderate to severe fat under the chin, also known as submental fullness. It contains deoxycholic acid, a naturally occurring molecule in the body that helps break down and absorb fat. When injected into the submental area, Belkyra targets and destroys fat cells, resulting in a more contoured and defined chin profile.

How does Belkyra Work?

Belkyra (Kybella) works by containing synthetic deoxycholic acid, which is a molecule naturally produced by the body to help break down and absorb dietary fat in the intestines. When injected into the submental area (under the chin), Belkyra destroys fat cells by disrupting their cell membranes. This process is called lipolysis. The destroyed fat cells are then gradually eliminated by the body’s natural processes, resulting in a noticeable reduction in submental fullness. The number of treatments required may vary depending on the individual’s response to the medication,

Are There Any Side Effects?

Belkyra (Kybella) may cause some side effects, which can include:

  • Swelling, bruising, pain, numbness, redness, and itching at the injection site
  • Difficulty swallowing
  • Numbness or tingling in the face, neck, or chin
  • Rash or hives
  • Temporary nerve injury in the jaw or chin, causing an uneven smile or facial muscle weakness
  • Injection site scarring
  • Muscle spasms in the face or neck
  • Temporary trouble breathing

Frequently Asked Questions

The number of treatments required may vary depending on the individual’s response to the medication, but typically, a series of 2-6 treatments spaced 4-6 weeks apart are recommended.
Belkyra is not suitable for everyone. It should not be used in individuals with an active infection or inflammation in the treatment area and should not be injected while wearing contact lenses. Belkyra should also not be injected while pregnant or breastfeeding, as there is no clinical data on its safety and effectiveness in these populations.
Results from Belkyra can be seen as early as two to four treatment sessions, but the full effects may take up to 12 weeks.
Belkyra is administered by a healthcare provider using a fine-gauge needle. The number of injections required will depend on the amount of submental fullness present.
Before starting Belkyra treatment, it’s essential to discuss any medical conditions, medications, or allergies with your healthcare provider. You should also avoid consuming alcohol and blood-thinning medications for at least 24 hours before treatment.